Posted: Mon., Mar. 14, 1994

Viacom takes over Paramount

By REUTERS

NEW YORK -- Viacom Inc. said Friday it has taken control of Paramount Communications.

Viacom said it bought 61.66 million shares, or 50.1%, of Paramount.

The cash-and-stock deal is valued by Wall Street analysts at $ 9.5 billion to $ 10.1 billion.

The moved followed by a day merger partner Blockbuster Entertainment's $ 1.25 billion investment in Viacom, completing the first part of the estimated $ 9.8 billion Par merger.

Viacom beat out QVC Network Inc. in a prolonged fight for the media and entertainment giant. After numerous rounds of bidding and legal maneuvering, Paramount last month accepted Viacom's sweetened offer of $ 107 a share for slightly more than half of Par's outstanding stock.

Viacom also said it designated a majority of the Paramount board of directors to remain in that capacity until Paramount becomes a wholly owned subsidiary of Viacom, it said.

Viacom owns and operates a large group of basic and premium networks, including MTV, MTV Europe, Showtime, VH-1, Nickelodeon, Nick at Nite and the Movie Channel.

Paramount's stock was off 25 cents at $ 44.50 on the New York Stock Exchange at Friday's close. Viacom's Class B shares finished at $ 25.88, up 25 cents on the American Stock Exchange.


TALKBACK:

Have an opinion about this article? Be the first to comment




Q What are the top 3 things affecting our industry today?
A. Daena - 1.) The internet 2.) HD Technology 3.) The impending recessionmore >


Submit this form
Tressa, one of the many stars of A&E's 'Intervention,' talks about her lengthy battle with methamphetamine. ; reality show; intervention; A&E; emmy contenders; drug addicts; variety; Interviews with Erick McCormack, Daniel Dae Kim & Christa Miller, stars of A&E's new sci-fi thriller, 'The Andromeda Strain.'; Erick McCormack; A&E; tv; sci-fi; The Andromeda Strain; variety; Daniel Dae Kim & Christa Miller;


© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.